SCHEMBL23383172

SCHEMBL23383172

CC1(OC(=O)c2ccc(C(=O)OC3(C(F)(F)C(=O)O)CCCCC3)cc2)CCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.37
▸ ADORA3 P0DMS8 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ SCN1A P35498 2/20 0.32
▸ SCN2A Q99250 2/20 0.32
▸ SCN3A Q9NY46 2/20 0.32
▸ HTR7 P34969 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ NPC1 O15118 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23382837 0.90 ADORA3 (0.35) CYP19A1ADORA3MEN1CYP1A2CYP3A4
SCHEMBL23382836 0.90 ADORA3 (0.35) CYP19A1ADORA3MEN1CYP1A2CYP3A4
SCHEMBL23383176 0.87 SCN1A (0.43) CYP19A1MEN1CYP3A4CYP2D6CYP2C9
SCHEMBL23383170 0.85 CA12 (0.38) ADORA3ALDH1A1
SCHEMBL23383169 0.85 SMN1; SMN2 (0.34) ADORA3MEN1CYP1A2CYP3A4CYP2D6
SCHEMBL23382835 0.83 ADORA3 (0.43) ADORA3MEN1CYP1A2CYP3A4CYP2D6
SCHEMBL23383171 0.80 KDM4E (0.37) ADORA3MEN1CYP3A4KMT2ASMN1; SMN2
SCHEMBL23382995 0.80 CYP19A1 (0.39) CYP19A1ADORA3MEN1CYP1A2CYP3A4
SCHEMBL23382487 0.78 MAPK1 (0.40) CYP19A1ADORA3MEN1CYP1A2CYP3A4
SCHEMBL23518972 0.78 ADORA3 (0.40) CYP19A1ADORA3CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process IDUA, SLC6A5, SLC6A9 CYP19A1 4062/4885ADORA3 2841/4885MEN1 3334/4885
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS IDUA, SLC6A5, SLC6A9 CYP19A1 4062/4885ADORA3 2841/4885MEN1 3334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback